Bigul

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Allotment Of 31,100 Equity Shares To Non-Promoter Upon Conversion Of Warrants Into Equity Shares

We would like to inform that the Warrant Holders have paid the balance of the consideration aggregating to Rs. 1,54,90,910/- and have applied for exercising their rights for conversion of 31,100 warrants into equivalent number of Equity Shares. Consequently, the Board of Directors in its meeting held on i.e. August 10, 2023 has allotted 31,100 Equity Shares of face value Rs. 10/-each to the warrant holder
10-08-2023
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation under Regulation 39(3) of SEBI (LODR) Regulations, 2015 for Loss of of Share Certificates
07-08-2023
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press release titled "Fredun Pharmaceuticals achieves a remarkable milestone in pet care division".
04-08-2023
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Revised Unaudited Financial Results For The Quarter Ended 30Th June, 2023

Unaudited Financial Results along with Limited Review Report for the quarter ended 30th June, 2023
02-08-2023
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Allotment Of 15,000 Equity Shares To Non-Promoter Upon Conversion Of Warrants Into Equity Shares

This is to inform you that Board of the Directors of the Company had pursuant to the approval of Shareholders in their Extra-Ordinary General Meeting held on September 23, 2022, has done allotment of convertible warrants on Preferential Basis to Non-Promoters on October 15, 2022. Further, we would like to inform that the Warrant Holders have paid the balance of the consideration aggregating to Rs. 1,11,97,750/- and have applied for exercising their rights for conversion of 15,000 warrants into equivalent number of Equity Shares. Consequently, the Board of Directors in its meeting held on i.e. August 02, 2023 has allotted 15,000 Equity Shares of face value Rs. 10/- each to the warrant holders.
02-08-2023
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release- Fredun Pharmaceuticals achieves a remarkable milestone in Pet Care Division
31-07-2023
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Clarification sought from Fredun Pharmaceuticals Ltd

The Exchange has sought clarification from Fredun Pharmaceuticals Ltd on July 28, 2023 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
28-07-2023
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

With reference to the above captioned subject, this is to bring to your kind attention that the Company has received intimation o 24th July, 2023 from Purva Shareregistry (India) Pvt Ltd., the Share Transfer Agent of the Company, pertaining to loss/ misplacement of Original Share Certificate(s) and have requested for issuance of Duplicate Share Certificate(s); in lieu of their Original Share Certificate been lost.
26-07-2023
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper publication for Financial results for the Quarter ended 30th June,2023 as approved by the Board in its Meeting held on 19th July,2023
21-07-2023
Next Page
Close

Let's Open Free Demat Account